Department of Orthopedic Trauma Surgery, Haimen People's Hospital, Nantong, Jiangsu, China.
Department of Orthopedic Trauma Surgery, Shanghai Changzheng Hospital, Shanghai, China.
J Cell Mol Med. 2024 Apr;28(8):e18271. doi: 10.1111/jcmm.18271.
Integrin-based focal adhesion is one of the major mechanosensory in osteocytes. The aim of this study was to mine the hub genes associated with focal adhesion and investigate their roles in osteoporosis based on the data of single-cell RNA sequencing and RNA-sequencing. Two hub genes (FAM129A and RNF24) with the same expression trend and AUC values greater than 0.7 in both GSE56815 and GSE56116 cohorts were uncovered. The nomogram was created to predict the risk of OP based on two hub genes. Subsequently, the competing endogenous RNA network was established based on two hub genes, 14 microRNAs and five long noncoding RNAs. Meanwhile, transcription factors-hub gene network was established based on two hub genes and 14 TFs. Finally, 73 drugs were predicted, of which there were 13 drugs targeting FAM129A and 66 drugs targeting RNF24. In both mouse and human blood samples, FAM129A expression was decreased in granulocytes and RNF24 expression was increased in monocytes. In the mouse experiment, FAM129A and anti-RNF24 were found to partially alleviate the progression of osteoporosis. In conclusion, two hub genes related to focal adhesion were identified by combined scRNA-seq and RNA-seq analyses, which might supply a new insight for the treatment and evaluation of OP.
整合素基焦点黏附是成骨细胞中主要的机械感受器之一。本研究旨在基于单细胞 RNA 测序和 RNA 测序数据挖掘与焦点黏附相关的枢纽基因,并探讨它们在骨质疏松症中的作用。在 GSE56815 和 GSE56116 两个队列中,发现了两个具有相同表达趋势且 AUC 值均大于 0.7 的枢纽基因(FAM129A 和 RNF24)。根据两个枢纽基因创建了预测 OP 风险的列线图。随后,基于两个枢纽基因、14 个 microRNAs 和 5 个长链非编码 RNA 构建了竞争内源性 RNA 网络。同时,基于两个枢纽基因和 14 个 TF 构建了转录因子-枢纽基因网络。最后,预测了 73 种药物,其中针对 FAM129A 的药物有 13 种,针对 RNF24 的药物有 66 种。在小鼠和人血样本中,FAM129A 在粒细胞中的表达减少,而 RNF24 在单核细胞中的表达增加。在小鼠实验中,发现 FAM129A 和抗 RNF24 可部分缓解骨质疏松症的进展。总之,通过联合 scRNA-seq 和 RNA-seq 分析鉴定了两个与焦点黏附相关的枢纽基因,这可能为骨质疏松症的治疗和评估提供新的思路。